About/Charitable Organization/Spokane/Researching Type 1 Diabetes
Video Credit List is stored here http://broadcaster.beazil.net/public/credits/youtube/videos/42336 Juvenile Diabetes Research Foundation is the leading global organization funding T1D research. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF works every day to change this by amassing grassroots support, deep scientific knowledge and strong industry and academic partnerships to fund research.
The JDRF identity was created with these key considerations in mind. We have dropped the formal name “Juvenile Diabetes Research Foundation” from our identity and will be known simply as JDRF. This better reflects our commitment to work for ALL those with T1D.
The graphic element of “T1D” in the logo design reinforces our focus on T1D, while the “momentum lines” that frame the JDRF name help to communicate the energy and urgency with which we are pursuing our mission. Most important, it is reflective of both the progress we’ve made and the accelerated progress we aim for. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services If you live with T1D, you spend a lot of time thinking about your blood-sugar levels now and worrying about the complications that T1D may one day bring. You don’t want anyone else you love to ever know the physical, emotional and financial toll this disease takes. You want a cure. So does JDRF. And we are committed to funding the development of new therapies and treatments to keep people with T1D healthier, longer, until that cure is found. That’s why we invest in multiple therapeutic approaches to cure, prevent and treat T1D. We identify and invest in promising therapies in their early stages, helping researchers pursue innovative ideas and approaches. As of 2013, the top five employers in Spokane are the State of Washington, Spokane Public Schools, Providence Sacred Heart Medical Center and Children’s Hospital, the 92d Air Refueling Wing, and Spokane County. The largest military facility and employer, the 92d Air Refueling Wing, is stationed at Fairchild Air Force Base near Airway Heights. The leading industries in Spokane for the employed population 16 years and older were educational services, health care, and social assistance (26.5 percent), retail trade (12.7 percent), and arts, entertainment, recreation, and accommodation food services (10.4 percent). As the metropolitan center of the Inland Northwest, as well as parts of southern British Columbia and Alberta, Spokane serves as a commercial, manufacturing, transportation, medical, shopping, and entertainment hub. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To summarize, let’s point out the major points:
contribute,Accredited Charity,ultralente insulin,fasting plasma glucose value,Maturity-onset diabetes of the young,T1D complications,secondary diabetes,contribution,SMBG,mean glucose,gestational diabetes,maturity-onset diabetes of the young,Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Trial,glycemic control,Environmental Triggers,Research Home,HAPO Study,Aldesleukin,JDRF,insulinoma,get support,bariatric surgery,Team Cure Diabetes,Diabetes Control and Complications Trial,Stoke,VLDL cholesterol,glycemic control comparison,Glucose Control,Get Personal Support,care delivery systems,T1D damage,DPP,Low Blood Sugar,insufficient insulin production,Celiac Disease and Diabetes,Pancreas,VADT Trial,diabetes related complications,diabetes diagnosis,Pathaway to Prevention,Special Diabetes Program,donate to save,Countdown,(DCCT),Grassroots fundraising,impaired glucose tolerance,Inhaled Insulin,International,latent autoimmune diabetes in.